Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Wang, Y. Zhang, Y. Wang, J. Shi, N. Jin, H.

Enhancing influenza vaccination uptake: a systematic review and meta-analysis of intervention strategies

  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Agrawal, R. Rehman, T. Sinha, D. Chakraborty, P. Sakthivel, M. Kumar, D. Mitra, S. Karumathil, A. Kanungo, S. Pati, S.

Epidemiological trends and determinants of mumps outbreaks: a systematic review and meta-analysis

  • All age groups
  • Mumps
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Wu, P. C. Huang, I. H. Wang, C. W. Chung, W. H. Chen, C. B.

Erythema Multiforme and Epidermal Necrolysis Following COVID-19 Vaccines: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Pan, Y. Jia, Z. Zhang, Y. Wu, Y. Jiang, J.

Estimates of the global prevalence of occult hepatitis B virus infection in population under 18 years old: a systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Hepatitis B
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Liu, J. Zhang, Y. Zhang, H. Tan, H.

Estimating the effects of interventions on increasing vaccination: systematic review and meta-analysis

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Szondy, I. Lorincz, K. Walter, A. Mohammed, A. A. Hegyi, P. Kiss, N. Meznerics, F. A. Banvolgyi, A.

Evaluating cross-protection: Meningococcal vaccines show effectiveness in gonorrhoea prevention - A systematic review and meta-analysis

  • All age groups
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Jotautis, V. Sarantaki, A.

Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Hepatitis E
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Alandijany, T. A. Qashqari, F. S.

Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia

  • All age groups
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Siddiqui, E. Khan, M. S. Khalid, M. Chandani, H. K. Naeem, U. Khan, M. M. Wasti, S. O.

Evaluating the immunogenicity and safety of ID93 + GLA-SE in BCG-vaccinated healthy adults: a systematic review and meta-analysis of randomized controlled trials

  • Adults
  • Tuberculosis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Williams, L. R. Hombach, J. Marti, M.

Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy

  • All age groups
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...